1. Taylor JP, Brown RH, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197–206. https://doi.org/10.1038/nature20413
2. Van Damme P, Robberecht W, Van Den Bosch L (2017) Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis Model Mech 10:537–549. https://doi.org/10.1242/dmm.029058
3. Al-Chalabi A, Jones A, Troakes C, et al (2012) The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 124:339–352. https://doi.org/10.1007/s00401-012-1022-4
4. Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248–264. https://doi.org/10.1038/nrn3430
5. Shibata N, Hirano A, Kobayashi M, et al (1996) Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 55:481–490. https://doi.org/10.1097/00005072-199604000-00011
6. Mackenzie IRA, Bigio EH, Ince PG, et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427–434. https://doi.org/10.1002/ana.21147
7. Deng H-X, Zhai H, Bigio EH, et al (2010) FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol 67:739–748. https://doi.org/10.1002/ana.22051
8. Rosen DR, Siddique T, Patterson D, et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62. https://doi.org/10.1038/362059a0
9. Maruyama H, Morino H, Kawakami H (2016) [Causative Genes for Amyotrophic Lateral Sclerosis]. Brain Nerve 68:1081–1086. https://doi.org/10.11477/mf.1416200555
10. Gamez J, Corbera-Bellalta M, Nogales G, et al (2006) Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1? J Neurol Sci 247:21–28. https://doi.org/10.1016/j.jns.2006.03.006
11. Cooper-Knock J, Hewitt C, Highley JR, et al (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135:751–764. https://doi.org/10.1093/brain/awr365
12. Neumann M, Sampathu DM, Kwong LK, et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133. https://doi.org/10.1126/science.1134108
13. Thomas M, Alegre-Abarrategui J, Wade-Martins R (2013) RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 136:1345–1360. https://doi.org/10.1093/brain/awt030
14. Chen S, Sayana P, Zhang X, Le W (2013) Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener 8:28. https://doi.org/10.1186/1750-1326-8-28
15. Renton AE, Chiò A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17:17–23. https://doi.org/10.1038/nn.3584
16. MacNair L, Xiao S, Miletic D, et al (2016) MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis. Brain 139:86–100. https://doi.org/10.1093/brain/awv308
17. Bakkar N, Kovalik T, Lorenzini I, et al (2018) Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. Acta Neuropathol 135:227–247. https://doi.org/10.1007/s00401-017-1785-8
18. Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:R46-64. https://doi.org/10.1093/hmg/ddq137
19. D’Ambrogio A, Buratti E, Stuani C, et al (2009) Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res 37:4116–4126. https://doi.org/10.1093/nar/gkp342
20. Hoell JI, Larsson E, Runge S, et al (2011) RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol 18:1428–1431. https://doi.org/10.1038/nsmb.2163
21. Gass J, Lee WC, Cook C, et al (2012) Progranulin regulates neuronal outgrowth independent of sortilin. Mol Neurodegener 7:33. https://doi.org/10.1186/1750-1326-7-33
22. Lagier-Tourenne C, Polymenidou M, Hutt KR, et al (2012) Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci 15:1488–1497. https://doi.org/10.1038/nn.3230
23. Kwon I, Xiang S, Kato M, et al (2014) Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345:1139–1145. https://doi.org/10.1126/science.1254917
24. Wen X, Tan W, Westergard T, et al (2014) Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84:1213–1225. https://doi.org/10.1016/j.neuron.2014.12.010
25. Farg MA, Konopka A, Soo KY, et al (2017) The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet 26:2882–2896. https://doi.org/10.1093/hmg/ddx170
26. Walker C, Herranz-Martin S, Karyka E, et al (2017) C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci 20:1225–1235. https://doi.org/10.1038/nn.4604
27. Zhang J, Liang H, Zhu L, et al (2018) Expression and Distribution of Arylsulfatase B are Closely Associated with Neuron Death in SOD1 G93A Transgenic Mice. Mol Neurobiol 55:1323–1337. https://doi.org/10.1007/s12035-017-0406-9
28. Jean-Philippe J, Paz S, Caputi M (2013) hnRNP A1: the Swiss army knife of gene expression. Int J Mol Sci 14:18999–19024. https://doi.org/10.3390/ijms140918999
29. Honda H, Hamasaki H, Wakamiya T, et al (2015) Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions. Neuropathology 35:37–43. https://doi.org/10.1111/neup.12153
30. Suzuki H, Matsuoka M (2017) hnRNPA1 autoregulates its own mRNA expression to remain non-cytotoxic. Mol Cell Biochem 427:123–131. https://doi.org/10.1007/s11010-016-2904-x
31. Sreedharan J, Blair IP, Tripathi VB, et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672. https://doi.org/10.1126/science.1154584
32. Vance C, Rogelj B, Hortobágyi T, et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211. https://doi.org/10.1126/science.1165942
33. Kim HJ, Kim NC, Wang Y-D, et al (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495:467–473. https://doi.org/10.1038/nature11922
34. Dreyfuss G, Matunis MJ, Piñol-Roma S, Burd CG (1993) hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 62:289–321. https://doi.org/10.1146/annurev.bi.62.070193.001445
35. Geuens T, Bouhy D, Timmerman V (2016) The hnRNP family: insights into their role in health and disease. Hum Genet 135:851–867. https://doi.org/10.1007/s00439-016-1683-5
36. Soulard M, Della Valle V, Siomi MC, et al (1993) hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res 21:4210–4217. https://doi.org/10.1093/nar/21.18.4210
37. Elliott DJ, Venables JP, Newton CS, et al (2000) An evolutionarily conserved germ cell-specific hnRNP is encoded by a retrotransposed gene. Hum Mol Genet 9:2117–2124. https://doi.org/10.1093/hmg/9.14.2117
38. Liu Y, Bourgeois CF, Pang S, et al (2009) The germ cell nuclear proteins hnRNP G-T and RBMY activate a testis-specific exon. PLoS Genet 5:e1000707. https://doi.org/10.1371/journal.pgen.1000707
39. Kanhoush R, Beenders B, Perrin C, et al (2010) Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts. Nucleus 1:109–122. https://doi.org/10.4161/nucl.1.1.10857
40. Hofmann Y, Wirth B (2002) hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. Hum Mol Genet 11:2037–2049. https://doi.org/10.1093/hmg/11.17.2037
41. Wang J, Gao Q-S, Wang Y, et al (2004) Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem 88:1078–1090. https://doi.org/10.1046/j.1471-4159.2003.02232.x
42. Pišlar AH, Zidar N, Kikelj D, Kos J (2014) Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells. Neuropharmacology 82:121–131. https://doi.org/10.1016/j.neuropharm.2013.07.040
43. Dai M, Liu Y, Nie X, et al (2015) Expression of RBMX in the light-induced damage of rat retina in vivo. Cell Mol Neurobiol 35:463–471. https://doi.org/10.1007/s10571-014-0140-z
44. Zhang J, Li D, Shen A, et al (2013) Expression of RBMX after spinal cord injury in rats. J Mol Neurosci 49:417–429. https://doi.org/10.1007/s12031-012-9914-2
45. Tsend-Ayush E, O’Sullivan LA, Grützner FS, et al (2005) RBMX gene is essential for brain development in zebrafish. Dev Dyn 234:682–688. https://doi.org/10.1002/dvdy.20432
46. Graves J a. M, Gécz J, Hameister H (2002) Evolution of the human X--a smart and sexy chromosome that controls speciation and development. Cytogenet Genome Res 99:141–145. https://doi.org/10.1159/000071585
47. Liu C, Shi Z, Fan L, et al (2011) Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 1374:100–109. https://doi.org/10.1016/j.brainres.2010.11.061
48. Rong W, Wang J, Liu X, et al (2012) Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury. Neurochem Res 37:1615–1623. https://doi.org/10.1007/s11064-012-0756-7
49. Ayala YM, De Conti L, Avendaño-Vázquez SE, et al (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30:277–288. https://doi.org/10.1038/emboj.2010.310
50. Koyama A, Sugai A, Kato T, et al (2016) Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res 44:5820–5836. https://doi.org/10.1093/nar/gkw499
51. Deshaies J-E, Shkreta L, Moszczynski AJ, et al (2018) TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis. Brain 141:1320–1333. https://doi.org/10.1093/brain/awy062
52. Suzuki H, Shibagaki Y, Hattori S, Matsuoka M (2015) Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Hum Mol Genet 24:1513–1527. https://doi.org/10.1093/hmg/ddu563